The Department of Health and Social Care (DHSC) has today (18/03/2026) confirmed the following initial list of price concessions for March 2026: Drug Pack size Price concession Betamethasone 500microgram soluble tablets sugar free 100 £46.50 Carbocisteine 375mg capsules 120 £3.18 Cefalexin 250mg/5ml oral suspension sugar free 100 £4.52 Clobazam 10mg tablets 30 £2.51 Co-codamol 30mg/500mg
Read moreIncome Support and Income-based Jobseeker’s Allowance are to be abolished by the Department for Work and Pension (DWP) from 1 April 2026. Some payments will continue to be made for a two-week run-on period to provide transitional protection, which means that people may continue to claim exemption from prescription charges on the grounds of Income
Read moreLocal Pharmaceutical Committee (LPC) Chairs from across the country came together this week to share experiences, strengthen leadership skills and discuss the support that LPCs provide to their LPC team and local pharmacy owners during this time of mounting pressure upon the sector. The Forum of LPC Chairs, provided an important opportunity for new and
Read moreTo help prepare for new legislation, pharmacy owners are being encouraged – although not legally required – to sign up for NHS England’s Sexual Safety Charter. Here is key information for pharmacy owners about this. NHS England and ICB ask NHS England is continuing to ask ICBs to follow up with primary care providers, including pharmacy owners, encouraging them to sign up to the NHS
Read moreMHRA Class 2 Medicines Recall: Curaleaf Laboratories, Curaleaf Oil [FS] 10mg/ml THC, 10mg/ml CBD (Rokshaw Ltd) Drug alert number: EL(26)A/13 Date issued: 12 March 2026 Curaleaf Laboratories are recalling three batches of Curaleaf Oil [FS] 10mg/ml THC 10mg/ml CBD (30ml) due to low THC content. DMRC reference number: DMRC-38668711 Company name:Rokshaw Limited Trading as Curaleaf Laboratories
Read moreMHRA Class 3 Medicines Recall:Bayer Plc, Various Products Drug Alert Number: EL(26)A/12 Date issued: 12 March 2026 Bayer Plc is recalling all stock of the products listed in this notification as a precautionary measure due to the identification of an impurity above the acceptable limit. The recall is at pharmacy and wholesaler level. DMRC reference number:
Read more
With Good Friday (3rd April) bank holiday occurring in the first five days of April 2026, pharmacy owners will be afforded an extra day, 6th April, to submit their FP34C declaration using the Manage Your Service (MYS) portal. However, this year, the 6th April is also a bank holiday (Easter Monday) which means that the
Read moreThis briefing provides guidance for community pharmacy owners on the Terms of Service opening hours requirements for bank holidays for the remainder of 2026 and in 2027. Briefing: Pharmacy bank holiday opening hours for the remainder of 2026 and in 2027 The post Briefing 004/26: Pharmacy bank holiday opening hours in the remainder of 2026 and
Read moreThe deadline to respond to the 2026 Pharmacy Pressures Survey has been extended to 10am on Monday 13th April. Our annual survey monitoring the health of the sector is waiting to hear from pharmacy owners and pharmacy team members like you. Your experiences of pressures such as rising costs and medicine supply issues provide the essential
Read more
MHRA Class 2 Medicines Recall: Ramipril 5mg capsules (Crescent Pharma Limited) Drug alert number: EL(26)A/11 Date issued: 06 March 2026 Crescent Pharma Limited is recalling one batch of Ramipril 5 mg Capsules as a precautionary measure due to a potential error at the manufacturing site. DMRC reference number: DMRC-38717889 Company name: Crescent Pharma Limited Medicine Details
Read more
